Unstructured is thrilled to announce that we have successfully raised $40 million in our latest funding round, a significant milestone that will turbocharge our mission to empower organizations with seamless access to their invaluable data. At Unstructured, we recognize that the world revolves around documents—from essential research reports and memos to crucial quarterly filings and plans of action. Unfortunately, a staggering 80% of this information remains ensnared in inaccessible formats, leading to inefficient decision-making and repetitive work for countless businesses. This large injection of capital will allow us to enhance our technology that captures unstructured data from various sources and transforms it into AI-friendly JSON files. Our innovative solution enables companies who are eager to integrate AI into their processes to finally unlock the hidden potential of their data. The funds will also support the expansion of our engineering team, further developing our platform’s capabilities, and accelerating the launch of new features that cater to the evolving needs of our clients. With this investment, Unstructured is poised to dismantle the barriers of accessibility, equip organizations with the tools they need to harness the power of AI, and ultimately drive more efficient decision-making. This funding is not just a financial boost; it’s a step toward a future where no data is left behind, and every organization can turn their unstructured information into actionable insights. We are excited to share this journey with our investors and clients as we reshape the way businesses interact with their data.

Unstructured Secures $40 Million in Series B Funding to Revolutionize AI-friendly Data Access
Get the full Unstructured company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Alitheon
Alitheon provides the last solution you will need for identification, authentication, and traceability of parts and products with our fail-proof, simple-to-use FeaturePrint system. FeaturePrint is an advanced machine-vision technology that provides for items, what fingerprints are for people – a unique and persistent identifier for the one in millions. FeaturePrint serializes items. As such, it enables track & trace, eliminates counterfeits and gray markets, and reduces human error ....all with just a photo using a standard camera. No bar codes, No QR codes, No stickers, No tags, No 'invisible' dust, No markers, No holograms, No special cameras, No special lighting, No Nonsense!
$8.0M Series a
today

The Ryl Company™
The Ryl Company™ is The Modern Tea Company — where nostalgic taste, clean ingredients, and functional benefits come together. Our flagship brand, Ryl Tea, reimagines the classic tea experience with zero sugar, 5 calories or less, nothing artificial, and antioxidant-powered functionality. We believe better-for-you should taste like the flavors you grew up loving. That’s why we exist: to help people Rethink Your Liquids (RYL). Available nationwide.
$20.0M Series c
today

Tavo Biotherapeutics
Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology. TAV-001 engages two novel targets that represent fundamental mechanisms underlying the pathology of glaucoma-related neurodegeneration. In pre-clinical studies, TAV-001 has shown signals of neuroprotection as well as substantial reduction in intraocular pressure, suggesting that it could represent the first disease-modifying pharmaceutical therapy for these patients. TAV-001 is expected to enter a Phase 1 clinical trial in glaucoma patients in 2025. TAV-002 represents a potential first-in-class treatment for retinal disease, including diabetic retinopathy, diabetic macular edema, and both wet and dry age-related macular degeneration. Tavo has initiated IND-enabling activities for this program.
$17.0M Series a
today

Adaptive Innovations Corp
Adaptive Innovations is an engineering firm and system integrator specializing in the design, fabrication, integration, and installation of custom equipment, automation & robotic solutions, tooling, fixtures, and gages. Comprised of a diverse group of professional engineers with backgrounds in design, controls, manufacturing, and electrical engineering disciplines, our outstanding team can help position your company to compete in today’s global economy. Combining industry best designs with exceptional process knowledge, fed by cross-industry exposure, Adaptive sets itself apart from its competition through every step of a project. We have a history of consistently delivering cost effective solutions, an excellent on-time delivery record, and unparalleled customer service, making Adaptive the engineering partner you can count on. Adaptive is considered the market leader in the design and fabrication of environmental test fixtures for testing such as HALT/HASS, ESS, and ED vibration or combined environments. We have experience with a wide array of automated solutions, including, assembly, pick-n-place, adhesive dispense, soldering, sorting, inspection etc. We're a Fanuc approved integrator, and have also integrated robots from ABB, Epson, Denso, and Adept. Our controls engineers are familiar with Beckhoff, Allen Bradley, Fanuc, Siemens, Mitsubishi, and National Instruments, contrllers and have a wide range of experience with robotic applications.
$50.0M Series a
today

Mia Health
Mia Health provides accurate risk assessments of large groups or populations which is crucial for the efficiency and resource optimization of health systems. With our customizable rapid screening and risk stratification platform you can now scale health systems significantly for more efficient and cost-effective population health management. Mia Health enables anyone to rapidly screen and stratify patient risk profiles using data collected through a smartphone in just 60 seconds. By measuring key vitals and providing critical insights to inform clinical or systemic decision-making, Mia Health simultaneously enables patient recommendations once a clinical decision has been made. Our proprietary cognitive AI encodes the expertise of dozens of world leading physicians making the Mia Health platform the most informed health stratification tool in the world and the only one of its kind. This eagerly anticipated and desperately needed technology is drastically closing the gap on delivering accessible, equitable care to all those who need it regardless of geographic location, economic status, race or gender. Learn More: https://www.miahealth.io
$920.0K Seed
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() MJOLNIR SPACEWORKS Japan | Series b | $11.1M | today |
| 2 | ![]() Advanced NanoTherapies, Inc United States | Series b | $31.0M | today |
| 3 | ![]() FRANQ The Netherlands | Series b | $12.4M | today |
| 4 | ![]() Tripo AI United States | Series b | $200.0M | today |
| 5 | ![]() Saris AI | Series b | $35.0M | today |




